News about Global Pharma

Glenmark Appoints Anurag Mantri as President

Mantri brings over 30 years of leadership experience across corporate finance, IPOs, M&A, and global compliance.

Global Pharma | 07/04/2025 | By Aishwarya |  287

UPLIZNA Becomes First and Only FDA-Approved Therapy for IGG4-Related Disease

The FDA granted Breakthrough Therapy Designation to UPLIZNA for the treatment of IgG4-RD, recognising the high unmet medical need in this serious condition and the medicine's potential to benefit patients.

Global Pharma | 05/04/2025 | By Abha |  420

Dr. Sanjay Keswani to Lead Medical Strategy at Neurocrine Biosciences as New CMO

Dr. Keswani, who has more than 20 years of pharmaceutical industry experience with broad R&D expertise in multiple therapeutic areas, will lead the clinical development and medical affairs activities at Neurocrine.

Global Pharma | 05/04/2025 | By Abha |  412

DHL Group Acquires CRYOPDP from Cryoport to Boost DHL Health Logistics

Going forward, DHL Supply Chain will further build the potential of its Pharma Specialized Network solution by leveraging the specialty courier expertise of newly acquired CRYOPDP and the global air capabilities of DHL Express and DHL Global Forwarding.

Global Pharma | 05/04/2025 | By Aishwarya |  332

Novartis Completes Acquisition of Anthos Therapeutics for Up to USD 3.1 Billion

Anthos was founded by Blackstone Life Sciences and Novartis in 2019 with the exclusive global rights from Novartis to develop, manufacture, and commercialise abelacimab.

Global Pharma | 04/04/2025 | By Abha |  744

Sai Life Sciences Establishes Peptide Research Centre in Hyderabad

Sai Life Sciences has inaugurated a state-of-the-art Peptide Research Centre at its Hyderabad R&D campus, expanding its capabilities in complex peptide synthesis and conjugation to support next-generation therapeutics.

Global Pharma | 04/04/2025 | By Abha |  340

MJFF Selects ONTOFORCE DISQOVER to Enhance Integration and Access of PD Research

DISQOVER, ONTOFORCE’s advanced knowledge discovery platform, will support MJFF’s Targets to Therapies Initiative, a program aimed to expand the number of promising, druggable biological targets within the Parkinson’s disease (PD) translational pipeline.

Global Pharma | 04/04/2025 | By Aishwarya |  182

Entos Pharmaceuticals and Circio to Develop Novel Platform for CircVec Circular RNA Delivery

Under the collaboration, Entos will develop and validate PLV-formulations of Circio´s circVec DNA vectors and perform technical testing in vivo.

Global Pharma | 04/04/2025 | By Aishwarya |  328

Append Medical Appoints Shlomi Nachman as Chairman of the Board

Append Medical announce the appointment of Shlomi Nachman as Chairman of the Board. This strategic move reflects the company's commitment to advancing its mission of reducing stroke risks for patients with atrial fibrillation through groundbreaking technology.

Global Pharma | 03/04/2025 | By Manvi |  153

Gland Pharma Secures USFDA Approval for Acetaminophen Injection

Gland Pharma has received USFDA approval for its Acetaminophen Injection, a bioequivalent version of B. Braun Medical’s product, used for managing mild to moderate pain. The company plans to launch the product soon through its marketing partner.

Global Pharma | 03/04/2025 | By Manvi |  547